Cancer, Advanced Completed Phase 1 Trials for Temsirolimus (DB06287)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00761644Doxil, Bevacizumab and Temsirolimus TrialTreatment
NCT00610493Bevacizumab and Temsirolimus in Patients With Advanced MalignancyTreatment
NCT00770731Study of Temsirolimus, Topotecan, and BortezomibTreatment